News Briefs: New MA and Part D Rule Is Pending at OMB | Nov. 18, 2021

The Biden administration’s first Medicare Advantage and Part D regulation is pending review at the Office of Management and Budget. The CMS final rule, titled “Policy and Technical Changes to the Medicare Advantage Program and Medicare Prescription Drug Benefit Program; MOOP and Cost Sharing Limits (CMS-4190),” was received on Nov. 10. It is not economically significant, according to the posting at RegInfo.gov.

© 2021 MMIT

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues, including drug benefits and specialty pharmacy, for more than a decade. She served as editor of Drug Benefit News (the predecessor to Radar on Drug Benefits) from 2004 to 2005 and again from 2011 to 2016, and now manages Radar on Medicare Advantage. Lauren graduated from Vassar College with a B.A. in English.

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured-Image-radar-on-medicare-advantage-Industry-Groups-Get-in-Front-of-Potential-Medicare-Advantage-Cuts.jpg
November 4

Industry Groups Get in Front of Potential Medicare Advantage Cuts

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/08/post-default-img.jpg
June 17

Aduhelm’s Approval May Come at Major Cost to Medicare

Read More
https://www.mmitnetwork.com/wp-content/uploads/2021/08/post-default-img.jpg
July 15

Zing Health Aims to Put ‘Feet on the Street’ for the Underserved

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today